GENB: SEC Form SCHEDULE 13G filed by Generate Biomedicines Inc.
Stocks in this Quantisnow insightHealth Care
Historical context for GENB
Across the 3 sessions after earlier GENB headlines, the stock closed higher 1 times and lower 2 times, with a median move of 11.2% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | GENB | SPY |
|---|---|---|---|
| May 7, 2026 | Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update | -11.2% | -0.3% |
| Apr 13, 2026 | H.C. Wainwright initiated coverage on Generate Biomedicines with a new price target | +12.2% | +1.0% |
| Mar 24, 2026 | Piper Sandler initiated coverage on Generate Biomedicines with a new price targetand 4 other headlines that session | -3.9% | -0.3% |
Quantisnow market dataNASDAQ
GENB
Generate Biomedicines Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2026
Get push alerts for GENB
Full GENB profile on Quantisnow Follow GENB and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time